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Introduction
At all times and in all cultures, ethics has been at the
heart of medicine. Medical ethics guides physicians in
their relationships with patients, colleagues and society
in general. It provides standards of behavior and
decision-making that enable physicians to know what
is expected of them by their colleagues, their patients
and society in general. It also sheds light on major
social issues that affect the practice of medicine, such
as abortion, organ transplantation, euthanasia and
medical research.
There are considerable variations in medical ethics
from one country to another, inasmuch as ethics is
grounded in philosophy, religion and political ideology.
Pioneers of Chinese medical ethics, such as Sun Ssu-
Miao (581–682) and Lu Chih (754–805), drew their
inspiration from Confucian, Buddhist and Taoist
teachings.1 Beginning with Song Guo-Bin (1893–
1956), Chinese ethicists have integrated Confucian
with Western medical ethics.2 Although differences of
emphasis and interpretation remain, the fundamentals
of medical ethics are basically the same across cultures,
as is evident in the widespread acceptance of the ethical
policies of the World Medical Association (WMA).
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Contemporary medical ethics deals with a large
number of topics in medical practice, medical research
and public policy. The focus of this article will be
selected ethical issues in clinical practice, that is, those
that arise from and affect physicians’ relationships with
patients. The topics to be treated include physicians’
duty of confidentiality in a digital environment, their
responsibilities for dealing with abuses of the human
rights of patients, their role in clinical research, and
their relationships with commercial enterprises. These
topics have a common theme – the conflict between 2
or more opposing values or interests. The article will
conclude with reflections on the need for international
standards of medical ethics.
Confidentiality
During the past decade, the traditional medical ethical
principle of confidentiality, that is, the physician’s duty
to protect the patient’s personal health information, has
come into increasing conflict with a perceived need for
health information databases serving administrative,
planning and research purposes. Computerization has
greatly facilitated the establishment and linking of such
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databases and, thereby, has made breaches of con-
fidentiality much easier. In response, many govern-
ments have adopted laws to regulate health data-
bases. These laws have generated much controversy:
privacy advocates complain that they are more about
facilitating access to personal health information than
protecting privacy, whereas administrators, researchers
and some medical associations criticize the bureaucratic
requirements that the laws impose on routine medical
and research practices.
Genetic databases and biobanks have been of
particular concern because of the sensitive nature of
personal genetic information as well as its commercial
value. At its 2002 General Assembly in Washington,
DC, the WMA adopted a major policy statement on
health databases.3 The initial impetus for this policy
was a request from the Icelandic Medical Association
to support its opposition to certain aspects of proposed
legislation on the creation of a comprehensive genetic
database in that country, particularly the provisions on
consent.
Numerous national medical associations have been
very active in lobbying their governments for legislation
and regulations that protect patient information while
facilitating its exchange for patient care and legitimate
administrative and research purposes. To help their
members interpret and implement the requirements
of database legislation in their jurisdictions, several
associations have prepared guidance documents and
related tools.4–6
Physicians have strong reasons for preserving con-
fidentiality. In order to receive medical care, patients
have to reveal personal information to physicians and
others who may be total strangers to them—information
that they would not want anyone else to know. They
must have good reason to trust their physicians not to
divulge this information. The basis of this trust is the
ethical and legal standards of confidentiality that
physicians and other health care professionals are
expected to uphold. Without an understanding that
their disclosures will be kept secret, patients may with-
hold personal information. This can hinder physicians
in their efforts to provide effective interventions or to
attain important public health goals.
Physicians also see the need for limited disclosure
of their patients’ health information – to other health
care providers to assist in the care of the patients,
to insurance companies and other agencies for
reimbursement of payment for health services, and to
database managers for public health, health system
administration and research purposes. As a general
rule, physicians should give priority to the patient’s
interests over those of others. Disclosure of personal
health information should protect patient confi-
dentiality as much as possible. Where confidentiali-
ty cannot be maintained, patients should be informed
about how their personal health information will be
used and whether the information will be identifiable
or anonymized.
Human Rights Abuses
Physicians are often among the first to be aware of
violations of human rights since they are called upon
to deal with the medical sequelae of torture and
inhuman treatment. However, they often find them-
selves constrained from dealing with these violations
because of pressure from the governments, military
or police who authorize or commit abuses. The
ethical challenge is how to protect the patient in the
face of such pressure.
Physician participation in torture has long been
regarded as a serious violation of medical ethics. The
1975 WMA Declaration of Tokyo: Guidelines for Medical
Doctors Concerning Torture and Other Cruel, Inhuman
or Degrading Treatment or Punishment in Relation to
Detention and Imprisonment,7 forbids any such
participation on the grounds that there must be “no
use made of any medical knowledge contrary to the
laws of humanity”.
In 1997, the WMA Assembly adopted the
Declaration of Hamburg Concerning Support for
Medical Doctors Refusing to Participate in, or to
Condone, the Use of Torture or Other Forms of Cruel,
Inhuman or Degrading Treatment,8 which called on
the medical profession to actively oppose torture and
to support physicians who speak out against such
violations of human rights.
The 2003 WMA Assembly in Helsinki adopted a
Resolution on the Responsibility of Physicians in the
Denunciation of Acts of Torture or Cruel or Inhuman
or Degrading Treatment of which they are Aware9 that
provides specific guidance to physicians who are in this
situation. In particular, physicians should guard their
professional independence to determine the best
interests of the patient and should observe, as far as
possible, the normal ethical requirements of informed
consent and confidentiality. Any breach of these
requirements must be justified and must be disclosed
to the patient. Physicians should report to the
appropriate authorities any unjustified interference in
the care of their patients, especially if fundamental
human rights are being denied. The Resolution
encourages national medical associations to promote
laws and programs for the abolition of torture.
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When physicians have responsibilities and are
accountable both to their patients and to a third party
and when these responsibilities and accountabilities
are incompatible, they find themselves in a situation of
“dual loyalty”. Third parties that demand physician
loyalty include governments, employers (e.g. hospitals
and managed health care organizations), insurers,
military officials, police, prison officials and family
members.
An important resource for physicians and other
health care professionals involved in dual loyalty
situations is the report of the International Dual
Loyalty Working Group, a collaborative initiative of
Physicians for Human Rights and the School of Public
Health and Primary Health Care, University of Cape
Town, South Africa.10 It contains chapters on the
dimension of the problem, proposed general guidelines
for health professional practice, proposed guidelines
for practice in difficult settings, and institutional
mechanisms to protect human rights in health practice.
Physicians working in prisons face many dual loyalty
conflicts. To help identify and deal with these issues,
the Norwegian Medical Association, in collaboration
with the WMA, is offering a web-based course on
human rights and ethics directed specifically towards
prison doctors.11
In addition to combating gross violations of human
rights such as torture, physicians are expected to
uphold the other basic human rights of their patients
and colleagues. The ones that are especially important
for medical ethics include the right to life, to freedom
from discrimination, to freedom of opinion and
expression, to equal access to public services in one’s
country, and to medical care. Oaths and codes of
medical ethics, such as the WMA’s Declaration of
Geneva, require that physicians not “permit
considerations of age, disease or disability, creed,
ethnic origin, gender, nationality, political affiliation,
race, sexual orientation, or social standing to intervene
between my duty and my patient.”
The Physician’s Role in Medical Research
All physicians make use of the results of medical
research in their clinical practice. To maintain their
competence, physicians must keep up with the current
research in their area of practice through continuing
medical education (CME)/continuing professional
development (CPD) programs, medical journals, and
interaction with knowledgeable colleagues. Even if
they do not engage in research themselves, physicians
must know how to interpret the results of research and
apply them to their patients. Thus, a basic familiarity
with research methods is essential for competent
medical practice.
The most common method of research for practis-
ing physicians is the clinical trial. The rapid increase
in recent years in the number of ongoing trials has
required finding and enrolling ever-larger numbers of
patients to meet the statistical requirements of the
trials. Those in charge of the trials, whether independent
physicians or pharmaceutical companies, now rely on
many other physicians, often in different countries, to
enrol patients as research subjects.
Although such participation in research is valuable
experience for physicians, there are potential problems
that must be recognized and avoided. In the first place,
the physician’s role in the physician-patient relationship
is different from the researcher’s role in the researcher-
research subject relationship, even if the physician and
the researcher are the same person. The physician’s
primary responsibility is the health and well-being
of the patient, whereas the researcher’s primary
responsibility is the generation of knowledge, which
may or may not contribute to the research subject’s
health and well-being. Thus, there is a potential for
conflict between the 2 roles. When this occurs, the
physician role must take precedence over the researcher
role.
Another potential problem in combining these 2
roles is conflict of interest. Medical research is a well-
funded enterprise, and physicians are sometimes offered
considerable rewards for participating. These can
include cash payments for enrolling research subjects,
equipment such as computers to transmit the research
data, invitations to conferences to discuss the research
findings, and co-authorship of publications on the
results of the research. The physician’s interest in
obtaining these benefits can sometimes conflict with
the duty to provide the patient with the best available
treatment. It can also conflict with the right of the
patient to receive all the necessary information to make
a fully informed decision as to whether or not to parti-
cipate in a research study.
These potential problems can be overcome. The
ethical values of the physician apply to the medical
researcher as well. So there is no inherent conflict
between the 2 roles. As long as physicians understand
and follow the basic rules of research ethics, they
should have no difficulty participating in research as an
integral component of their clinical practice.
The foundational document of research ethics is
the WMA’s Declaration of Helsinki,12 first adopted in
1964 and amended several times since, most recently
in 2000. The Declaration is a concise summary of
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research ethics. Other, much more detailed, documents
have been produced in recent years on research ethics
in general (e.g. Council for International Organizations
of Medical Sciences, International Ethical Guidelines
for Biomedical Research Involving Human Subjects,
1993, revised in 2002)13 and on specific topics in
research ethics (e.g. Nuffield Council on Bioethics
[UK], The Ethics of Research Related to Healthcare in
Developing Countries, 2002, 2005).14
Despite the different scope, length and authorship
of these documents, they agree to a very large extent
on the basic requirements of research ethics, namely:
• every proposal for medical research on human
subjects must be reviewed and approved by an
independent ethics committee before it can proceed;
• a medical research project involving human subjects
must be justifiable on scientific grounds;
• a medical research project must contribute to the
well-being of society in general;
• the risks to the research subjects must not be
unreasonable or disproportionate to the expected
benefits of the research;
• research on human subjects cannot proceed without
their informed consent;
• research subjects have a right to privacy with regard
to their personal health information;
• research results must be reported accurately;
• anyone who has knowledge of unethical research
has an obligation to disclose this information to the
appropriate authorities.
These principles have been incorporated in the
laws and/or regulations of many countries and
international organizations, including those that deal
with the approval of drugs and medical devices.
Not all aspects of research ethics enjoy general
agreement. As medical science continues to advance in
areas such as genetics, the neurosciences, and organ
and tissue regeneration, questions arise regarding the
ethical acceptability of new techniques, procedures
and treatments for which there are no ready-made
answers. Moreover, some older issues are still subjects
of continuing ethical controversy, for example, under
what conditions should a placebo arm be included in
a clinical trial and what continuing care should be
provided to participants in medical research. At a
global level, the 10/90 gap in medical research (only
10% of global research funding is spent on health
problems that affect 90% of the world’s population) is
clearly an unresolved ethical issue. When researchers
do address problems in resource-poor areas of the
world, they often encounter problems due to conflicts
between their ethical outlook and that of the com-
munities where they are working. All these issues will
require much further analysis and discussion before
general agreement is achieved.
Physicians and Commercial Enterprises
The relationship between physicians and commercial
enterprises, particularly pharmaceutical and medical
device companies, has been a subject of intense scrutiny
by medical associations, medical journals and the
popular press for well over a decade. As for-profit
companies have become ever more prominent in the
funding of medical research and CME/CPD, the
potential for conflict of interest in the relationships of
physicians with these companies has increased.
Commercial enterprises such as pharmaceutical
and medical device companies depend on sales of their
products to survive and thrive. The more they sell and
the higher the price, the more successful they are. At
the same time, patients need these products to prevent
or treat illness. Those who pay for the products,
whether patients, insurers or governments, want to
pay as little as possible for them, particularly when
there are problems of affordability. Physicians are
caught in the middle between these 2 interests. They
want a wide range of effective products for their
patients, which means favoring the producers of the
products, but they also want their patients to have
access to the products, which may require curbs on the
profits of the companies.
In order to win the favor of physicians, pharma-
ceutical companies, medical device manufactur-
ers and other commercial organizations frequently
offer them gifts and other benefits that range from free
samples to travel and accommodation at educational
events to excessive remuneration for research activities.
A common underlying motive for such company
largesse is to convince the physician to prescribe or use
the company’s products, which may not be the best
ones for the physician’s patients. Physicians are then
faced with a conflict between their own interests and
those of the company, on the one hand, and the
interests of the patients, and perhaps of third-party
funders, on the other. To prevent these conflicts from
arising, and to help physicians deal with them when
they do occur, many national medical associations and
other medical organizations have developed policies
and educational resources on this topic.15–17 The WMA
recently adopted its own set of guidelines, which deal
with the funding of medical conferences, gifts to
physicians, participation in industry-sponsored
research, and other relationships of physicians with
commercial entities.18
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The basic general principle underlying all these
guidelines is that the physician must give priority to
the patient in any conflicts of interest. This requires
maintaining professional and clinical independence
from commercial interests and ensuring that rela-
tionships with companies do not lead to any action
that is not in the best interests of the patient. In
particular, physicians should not rely solely on
pharmaceutical company representatives or industry-
sponsored promotional events for their knowledge of
medicinal products, and they should not ask their
patients to take part in industry-sponsored research
studies unless the study fulfils all the ethical
requirements of the Declaration of Helsinki.
Conclusion
In an increasingly globalized world, the need for
international standards of medical ethics has never
been greater. Clinical trials often involve researchers
and patients in many different countries, and the
same ethical requirements must apply in all cases if
the trials are to receive approval. Outside the research
context, there remain differences in how general
ethical rules are applied, for example, with regard to
informed consent. In some countries, patients must
be told all they need and want to know about their
medical condition and the options for treatment so
that they can make informed decisions, whereas in
other countries, it is felt that terminally ill patients
should not be informed of their prognosis. However,
as both physicians and patients migrate in large
numbers from country to country, either temporarily
or permanently, there is an increasing need to rec-
ognize the fundamental similarities of the principles
of medical ethics everywhere and to reconcile the
different applications of these principles.
The many ethical statements and resolutions of the
WMA are proof that it is possible to reach international
consensus on the most difficult ethical issues in medical
practice. Such consensus does not always come easily;
it is often the result of considerable discussion and
consultation. Moreover, the policies require periodic
review, since both medical science and ethics do
evolve, sometimes at a very rapid pace. The WMA
recently instituted a systematic review process to ensure
that its policies remain up-to-date.19 Through these
activities and its close relationships with national medical
associations throughout the world, the WMA is
committed to ensuring that ethics will continue to be
at the very heart of medicine wherever it is practised.
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